Celltrion has announced groundbreaking results from a two-year study on dose escalation of subcutaneous infliximab (CT-P13 SC ...

The Scottish Medicines Consortium (SMC) has recommended MSD’s KEYTRUDA (pembrolizumab) as a monotherapy for adults with ...

Sanofi has announced the launch of its high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK. This vaccine is ...

This decision aligns with the recent approval by Scotland’s SMC to use teclistamab on the NHS. Teclistamab, a bispecific ...

Copenhagen-based biotech company FluoGuide A/S has announced the submission of a Clinical Trial Application (CTA) for a phase ...

IRLAB Therapeutics AB has announced the successful completion of the first part of its Phase I clinical trial for IRL757, a ...

Purespring Therapeutics has raised £80m in an oversubscribed Series B financing round. Syncona Ltd, a leading life science ...

In a landmark study, Johnson & Johnson has announced that ERLEADA (apalutamide) significantly reduces the risk of death by 23 ...

Cardiologists at Sheffield Teaching Hospitals NHS Foundation Trust have performed a cutting-edge heart valve replacement procedure live to an international audience. The streamlined transcatheter ...

As the NHS goes, so goes pharma – so when the government talks about ‘transforming’ the health service, the industry better listen. Our cover feature this month (p33) focuses on sustainability and ...

As the polls tighten and June’s general election starts to seem very close indeed, we’ve got a roundup of all the major parties’ manifestos and what they would mean for healthcare in the UK. But ...